GoldenGolden
Bay City Capital

Bay City Capital

Bay City Capital is a San Francisco-based company founded in 1997.

Bay City Capital is a San Francisco-based venture capital firm founded by Fred Craves and John Diekman in 1997. The firm actively invests in life sciences sector.

Bay City Capital invests in multiple stages, namely debt, early stage venture, late-stage venture and private equity.

As of November 2019, the company invested in general life sciences, nutrition and agribusiness sector.

Timeline

1997
Founded

People

Name
Role
LinkedIn

Fred Craves

Founder

John Diekman

Founder

Judy Koh

Managing Director / Chief Financial Officer

Matt Kronmiller

Vice President

Stacey Leanos

Senior Director / Marketing / Investor Relations

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

NextCure

Imara

Iterum Therapeutics

KBP Biosciences

Kezar Life Sciences

Menlo Therapeutics

Oculis

Twist Bioscience

Vtesse

News

Title
Author
Date
Publisher
Description
BioSpace
May 11, 2020
BioSpace
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with high unmet medical need, is pleased to announce the appointment of Dr. Manuel López-Figueroa of Bay City Capital as an independent director.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.